p 63 is an alternative p 53 repressor in melanoma that confers chemoresistance and a poor prognosis

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• p53 rescue through HDM2 antagonism suppresses melanoma growth and potentiates MEK inhibition.

  2012influential reference
• High-Level Expression of Wild-Type p53 in Melanoma Cells is Frequently Associated with Inactivity in p53 Reporter Gene Assays

  2011cited by this paper
• Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells

  2011cited by this paper
• E2F1-Dependent Oncogenic Addiction of Melanoma Cells to MDM2

  2011cited by this paper
• The melanoma ‘epidemic’, a dermatopathologist's perspective

  2011cited by this paper
• Analysis of the functional integrity of the p53 tumor-suppressor gene in malignant melanoma

  2011influential reference
• SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival

  2011cited by this paper
• P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation

  2011cited by this paper
• CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma

  2010cited by this paper
• Altered molecular pathways in melanocytic lesions

  2010cited by this paper
• Dominant negative (DeltaN) p63alpha induces drug resistance in hepatocellular carcinoma by interference with apoptosis signaling pathways.

  2010cited by this paper
• Chemotherapy‐induced apoptosis in hepatocellular carcinoma involves the p53 family and is mediated via the extrinsic and the intrinsic pathway

  2010cited by this paper
• Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma.

  2010cited by this paper
• p53 inactivation by MDM2 and MDMX negative feedback loops in testicular germ cell tumors

  2010cited by this paper
• Identification of the spiro(oxindole-3,3'-thiazolidine)-based derivatives as potential p53 activity modulators.

  2010cited by this paper
• Identification and functional characterization of two new transcriptional variants of the human p63 gene

  2009cited by this paper
• Redox-dependent translocation of p53 to mitochondria or nucleus in human melanocytes after UVA- and UVB-induced apoptosis.

  2009influential reference
• MDM4 (MDMX) localizes at the mitochondria and facilitates the p53‐mediated intrinsic‐apoptotic pathway

  2009cited by this paper
• Hsp70 molecular chaperones are required to support p53 tumor suppressor activity under stress conditions

  2009cited by this paper
• The relationship between p63 and p53 expression in normal and neoplastic breast tissue.

  2009cited by this paper
• Aberrant Cytoplasmic Expression of p63 and Prostate Cancer Mortality

  2009cited by this paper
• Immunohistochemical Distinction of Cutaneous Spindle Cell Carcinoma

  2008cited by this paper
• Uveal vs. cutaneous melanoma. Origins and causes of the differences

  2008cited by this paper
• DeltaNp63 expression is associated with poor survival in ovarian cancer.

  2008cited by this paper
• Small Molecular Weight Variants of p53 Are Expressed in Human Melanoma Cells and Are Induced by the DNA-Damaging Agent Cisplatin

  2008cited by this paper
• Transcriptional control of human p53-regulated genes

  2008cited by this paper
• Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expression

  2008cited by this paper
• Apoptosis-associated mitochondrial outer membrane permeabilization assays.

  2008cited by this paper
• p63 Expression in olfactory neuroblastoma and other small cell tumors of the sinonasal tract.

  2008cited by this paper
• Role of cytogenetics in management of uveal melanoma.

  2008cited by this paper
• The biology and management of uveal melanoma

  2008cited by this paper
• Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants

  2007cited by this paper
• Monoubiquitylation promotes mitochondrial p53 translocation

  2007cited by this paper
• p63 Is essential for the proliferative potential of stem cells in stratified epithelia.

  2007cited by this paper
• An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells.

  2007cited by this paper
• p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis.

  2006cited by this paper
• Overexpression of p 53 Is a Late Event in the Development of Malignant Melanoma 1

  2006cited by this paper
• p63 protects the female germ line during meiotic arrest

  2006cited by this paper
• p53 and Nur77/TR3 – transcription factors that directly target mitochondria for cell death induction

  2006cited by this paper
• p63: oncogene or tumor suppressor?

  2006cited by this paper
• Cytoplasmic localization of p63 is associated with poor patient survival in lung adenocarcinoma

  2006cited by this paper
• Adenovirus-mediated TA-p73β gene transfer increases chemosensitivity of human malignant melanomas

  2006cited by this paper
• One, two, three--p53, p63, p73 and chemosensitivity.

  2006cited by this paper
• p63 is a useful marker for cutaneous spindle cell squamous cell carcinoma

  2006cited by this paper
• HSP90 and the chaperoning of cancer

  2005cited by this paper
• TAp63α induces apoptosis by activating signaling via death receptors and mitochondria

  2005influential reference
• The post-translational phosphorylation and acetylation modification profile is not the determining factor in targeting endogenous stress-induced p53 to mitochondria

  2005cited by this paper
• Transcriptional Blockade Induces p53-dependent Apoptosis Associated with Translocation of p53 to Mitochondria*

  2005cited by this paper
• Ultraviolet radiation induces phosphorylation and ubiquitin-mediated degradation of DeltaNp63alpha.

  2005cited by this paper
• p63 is an essential proapoptotic protein during neural development.

  2005cited by this paper
• p63 deficiency activates a program of cellular senescence and leads to accelerated aging.

  2005influential reference
• The expression of TA and ΔNp63 are regulated by different mechanisms in liver cells

  2005cited by this paper
• p63/AMACR antibody cocktail restaining of prostate needle biopsy tissues after transfer to charged slides: a viable approach in the diagnosis of small atypical foci that are lost on block sectioning.

  2005cited by this paper
• Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family.

  2005cited by this paper
• PUMA expression is significantly reduced in human cutaneous melanomas

  2005cited by this paper
• PUMA Couples the Nuclear and Cytoplasmic Proapoptotic Function of p53

  2005cited by this paper
• p300 Regulates p63 Transcriptional Activity*

  2005cited by this paper
• Lack of correlation between p53-dependent transcriptional activity and the ability to induce apoptosis among 179 mutant p53s.

  2005cited by this paper
• DeltaNp63alpha levels correlate with clinical tumor response to cisplatin.

  2005cited by this paper
• Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas.

  2005cited by this paper
• Expression of the p53 protein in malignant melanomas as a prognostic indicator

  2005cited by this paper
• Melanocyte and keratinocyte carcinogenesis: p53 family protein activities and intersecting mRNA expression profiles.

  2005cited by this paper
• Distribution of melanoma specific antibody (HMB-45) in benign and malignant melanocytic tumours

  2004cited by this paper
• p53--an examination of sibling support in apoptosis control.

  2004cited by this paper
• Tbx2 Directly Represses the Expression of the p21WAF1 Cyclin-Dependent Kinase Inhibitor

  2004cited by this paper
• p53 gene family p51(p63)-encoded, secondary transactivator p51B(TAp63α) occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation

  2004cited by this paper
• Hsp90 Chaperones Wild-type p53 Tumor Suppressor Protein*

  2004cited by this paper
• p63 and p73 are not required for the development and p53-dependent apoptosis of T cells.

  2004cited by this paper
• Expression Profiling Reveals Novel Pathways in the Transformation of Melanocytes to Melanomas

  2004cited by this paper
• Detection of mitochondrial localization of p53.

  2003cited by this paper
• Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray

  2003cited by this paper
• Immunohistochemical Markers of Melanocytic Tumors

  2003cited by this paper
• Significance of p63 amplification and overexpression in lung cancer development and prognosis.

  2003cited by this paper
• Modeling gene-environment interactions in malignant melanoma.

  2003cited by this paper
• Positive and negative regulation of deltaN-p63 promoter activity by p53 and deltaN-p63-alpha contributes to differential regulation of p53 target genes.

  2003cited by this paper
• Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription.

  2003cited by this paper
• p53-related pathways and the molecular pathogenesis of melanoma

  2003cited by this paper
• P63-driven nuclear accumulation of beta-catenin is not a frequent event in human neoplasms.

  2003cited by this paper
• Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma

  2003cited by this paper
• Elevated expression of p63 protein in human esophageal squamous cell carcinomas

  2002cited by this paper
• HDM2 protein overexpression and prognosis in primary malignant melanoma.

  2002cited by this paper
• Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis.

  2002cited by this paper
• p63 expression profiles in human normal and tumor tissues.

  2002cited by this paper
• A C-Terminal Inhibitory Domain Controls the Activity of p63 by an Intramolecular Mechanism

  2002cited by this paper
• p63 and p73 are required for p53-dependent apoptosis in response to DNA damage

  2002cited by this paper
• Hdmx and Mdm2 can repress transcription activation by p53 but not by p63

  2001cited by this paper
• CUSP/p63 expression in rat and human tissues.

  2001cited by this paper
• Corrigendum to: Hypoxia death stimulus induces translocation of p53 protein to mitochondria

  2001cited by this paper
• Animal models of melanoma: recent advances and future prospects.

  2000cited by this paper
• Down-regulation of p63 is required for epidermal UV-B-induced apoptosis.

  2000cited by this paper
• p63 and p73: p53 mimics, menaces and more

  2000cited by this paper
• HMB-45 immunohistochemical staining of sentinel lymph nodes: a specific method for enhancing detection of micrometastases in patients with melanoma.

  2000cited by this paper
• AIS is an oncogene amplified in squamous cell carcinoma.

  2000influential reference
• Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells.

  2000cited by this paper
• DNA damage-induced activation of p53 by the checkpoint kinase Chk2.

  2000cited by this paper
• The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.

  2000cited by this paper
• p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis

  1999cited by this paper
• BCL-2 Is Phosphorylated and Inactivated by an ASK1/Jun N-Terminal Protein Kinase Pathway Normally Activated at G2/M

  1999influential reference
• p53 family genes: structural comparison, expression and mutation

  1999cited by this paper
• Linkage of ATM to cell cycle regulation by the Chk2 protein kinase.

  1998cited by this paper

• IL-1β induces up-regulation of BIRC3, a gene involved in chemoresistance to doxorubicin in breast cancer cells.

  2017cites this paper
• NRP1-positive lung cancer cells possess tumor-initiating properties

  2017cites this paper
• TBX3 Role in Colorectal Cancer Treatment

  2017cites this paper
• Anti carcinogenic Effect of Roman nettle Against chemical Induced Colon cancer in Sprague–Dawley Rats

  2016cites this paper
• Cell cycle control as a promising target in melanoma

  2015cites this paper
• The diverse oncogenic and tumour suppressor roles of p63 and p73 in cancer: a review by cancer site.

  2015cites this paper